Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ascendis Pharma Ads (NQ: ASND )

166.86 USD +1.94 (+1.18%)
Official Closing Price Updated: 5:09 PM EST, Dec 4, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 58,700
Open 166.32
Bid (Size) 166.31 (1)
Ask (Size) 166.87 (9)
Prev. Close 164.92
Today's Range 164.31 - 167.22
52wk Range 92.00 - 178.25
Shares Outstanding 41,779,122
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Ascendis Pharma A/S Announces Participation at the Evercore ISI 3rd Annual HealthCONx Virtual Conference
From GlobeNewswire News Releases
Ascendis Pharma A/S to Host Virtual Oncology R&D Day on Friday, November 20
From GlobeNewswire News Releases

Performance

YTD
+18.23%
+18.23%
1 Month
-4.54%
-4.54%
3 Month
+18.90%
+18.90%
6 Month
+18.36%
+18.36%
1 Year
+51.98%
+51.98%

More News

Read More
Ascendis Pharma A/S Reports Third Quarter 2020 Financial Results
From GlobeNewswire News Releases
Ascendis Pharma A/S Appoints Dr. Mark A. Bach as Senior Vice President of Clinical Development and Medical Affairs for Endocrinology Rare Diseases
From GlobeNewswire News Releases
Ascendis Pharma A/S Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 11
From GlobeNewswire News Releases
Ascendis Pharma A/S Receives Orphan Designation for TransCon™ PTH for Treatment of Hypoparathyroidism in Europe
From GlobeNewswire News Releases
Ascendis Pharma A/S Announces Presentations for its Endocrinology Rare Disease Clinical Programs at Upcoming Medical Conferences
From GlobeNewswire News Releases
10 Biggest Price Target Changes For Friday
Tags PDD ASND AKRO
From Benzinga
Recap: Ascendis Pharma Q3 Earnings
Tags Earnings Market News Benzinga
From Benzinga
Ascendis Pharma Earns Relative Strength Rating Upgrade
From Investor's Business Daily
Human Growth Hormone Deficiency (GHD) Drugs Market : Facts, Figures and Analytical Insights 2020-2023
From SBWire - Latest Press Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.